Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

BOLT

BOLT News

Newswire

08:31

Bolt Biotherapeutics shares surge 11.94% premarket as clinical data for BDC-4182 expected in 3Q 2026 and $38.8M cash runway extends into 2027.

03:58

Bolt Biotherapeutics Reports Q3 2025 Financial Results, Highlights Pipeline Progress, and Seeks Partner for Lead Candidate BDC-3042

16:49

Bolt Biotherapeutics shares surge 10.45% after-hours as extended cash runway into 2027 and BDC-4182 Phase 1 trial progress boost investor confidence.

16:11

Bolt Biotherapeutics Q3: $38.8mln cash balance, BDC-4182 Phase 1 data in Q3 2026.

19:23

Bolt Biotherapeutics Executives Buy 125 Shares Each at $5.49/Share.

View More

About BOLT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More